Alzamend Neuro, Inc. — Investor Relations & Filings
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. Its primary targets include Alzheimer's disease, Bipolar Disorder, Major Depressive Disorder (MDD), and Post-Traumatic Stress Disorder (PTSD). The company's pipeline consists of two therapeutic drug candidates licensed from the University of South Florida Research Foundation. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, proline, and salicylate. ALZN002 is a patented cell-based therapeutic vaccine designed to restore the patient's immunological system's ability to combat Alzheimer's disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEF 14A - ALZAMEND NEURO, INC. (0001677077) (Filer) | 2026-02-26 | English | |
| PRIMARY DOCUMENT | 2025-12-30 | English | |
| PRIMARY DOCUMENT | 2025-12-23 | English | |
| Interim / Quarterly Report 2026 | 2025-12-09 | English | |
| Regulatory Filings 2025 | 2025-11-18 | English | |
| PRIMARY DOCUMENT | 2025-10-24 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 32896473 | DEF 14A - ALZAMEND NEURO, INC. (0001677077) (Filer) | 2026-02-26 | English | ||
|
2025
14 filings
| |||||
| 12965128 | PRIMARY DOCUMENT | 2025-12-30 | English | ||
| 12965129 | PRIMARY DOCUMENT | 2025-12-23 | English | ||
| 12965132 | Interim / Quarterly Report 2026 | 2025-12-09 | English | ||
| 12965133 | Regulatory Filings 2025 | 2025-11-18 | English | ||
| 12965139 | PRIMARY DOCUMENT | 2025-10-24 | English | ||
| 12965134 | Regulatory Filings 2025 | 2025-10-14 | English | ||
| 12965153 | PRIMARY DOCUMENT | 2025-10-10 | English | ||
| 12965136 | Regulatory Filings 2025 | 2025-10-09 | English | ||
| 12965137 | PRIMARY DOCUMENT | 2025-10-08 | English | ||
| 12965138 | Major Shareholding Notification 2025 | 2025-10-08 | English | ||
| 12965150 | Major Shareholding Notification 2025 | 2025-10-04 | English | ||
| 12965140 | PRIMARY DOCUMENT | 2025-10-04 | English | ||
| 12965141 | Major Shareholding Notification 2025 | 2025-10-01 | English | ||
| 12965142 | PRIMARY DOCUMENT | 2025-10-01 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Alzamend Neuro, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35321/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35321 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35321 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35321 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35321}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alzamend Neuro, Inc. (id: 35321)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.